Tumor Targeted Low Dose Radiation and Immunotherapy in Mouse Models of Melanoma
Immune checkpoint blockade has increased overall survival in patients with multiple late-stage malignancies, including melanoma. Not all patients with melanoma will respond to immunotherapy, and there has been general interest in developing methods capable of boosting clinical response rates.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Allen Rossetti-Chung, Siddheshvar Bhela, Lindsey Claps, Jessica Lawrence, Vaiva Vezys Source Type: research
More News: Biology | Cancer & Oncology | Immunotherapy | Legislation | Melanoma | Physics | Radiology | Skin Cancer